Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia (Q37044749)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia |
scientific article |
Statements
1 reference
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia (English)
1 reference
1 reference
Philadelphia chromosome
2 August 2024
Michael Steinberg
1 reference
1 November 2007
1 reference
1 reference
29
1 reference
11
1 reference
2289-2308
1 reference
Identifiers
1 reference
1 reference